Condensed Consolidated Statements of Redeemable Noncontrolling Interest, Series A Redeemable Convertible Preferred Stock and Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands |
Total |
Redeemable noncontrolling interest - held for sale from discontinued operations |
Common Stock |
Additional Paid-In Capital |
Accumulated Other Comprehensive Income |
Accumulated Deficit |
| Beginning temporary equity at Dec. 31, 2024 |
$ 141,663
|
|
|
|
|
|
| Beginning temporary equity (in shares) at Dec. 31, 2024 |
150
|
|
|
|
|
|
| Series A Redeemable Convertible Preferred Stock |
|
|
|
|
|
|
| Accretion of Series A redeemable convertible preferred stock to redemption value |
$ 4,202
|
|
|
|
|
|
| Ending temporary equity (in shares) at Mar. 31, 2025 |
150
|
|
|
|
|
|
| Ending temporary equity at Mar. 31, 2025 |
$ 145,865
|
|
|
|
|
|
| Beginning balance (in shares) at Dec. 31, 2024 |
|
|
258,173
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
(56,356)
|
$ 52,375
|
$ 2
|
$ 1,328,015
|
$ 602
|
$ (1,384,975)
|
| Stockholders’ Equity |
|
|
|
|
|
|
| Issuance of common stock upon exercise of stock options, net of repurchases (in shares) |
|
|
256
|
|
|
|
| Issuance of common stock upon exercise of stock options, net of repurchases |
363
|
|
|
363
|
|
|
| Vesting of restricted stock units (in shares) |
|
|
2,064
|
|
|
|
| Shares withheld related to net share settlement of equity awards (in shares) |
|
|
(745)
|
|
|
|
| Shares withheld related to net share settlement of equity awards |
(2,971)
|
|
|
(2,971)
|
|
|
| Stock-based compensation |
7,202
|
|
|
7,202
|
|
|
| Unrealized (loss) gain on investments in marketable securities |
6
|
|
|
|
6
|
|
| Foreign currency translation gain (loss) |
(43)
|
|
|
|
(43)
|
|
| Accretion of redeemable noncontrolling interest to redemption value |
(1,254)
|
1,254
|
|
(1,254)
|
|
|
| Accretion of Series A redeemable convertible preferred stock to redemption value |
(4,202)
|
|
|
(4,202)
|
|
|
| Share repurchases (in shares) |
|
|
(923)
|
|
|
|
| Share repurchases |
(3,076)
|
|
|
(3,076)
|
|
|
| Reclassification of noncontrolling interest to equity, net of noncash consideration received |
52,675
|
(53,447)
|
|
52,675
|
|
|
| Net loss |
(9,517)
|
(182)
|
|
|
|
(9,517)
|
| Ending balance (in shares) at Mar. 31, 2025 |
|
|
258,825
|
|
|
|
| Ending balance at Mar. 31, 2025 |
(17,173)
|
0
|
$ 2
|
1,376,752
|
565
|
(1,394,492)
|
| Beginning temporary equity at Dec. 31, 2024 |
$ 141,663
|
|
|
|
|
|
| Beginning temporary equity (in shares) at Dec. 31, 2024 |
150
|
|
|
|
|
|
| Series A Redeemable Convertible Preferred Stock |
|
|
|
|
|
|
| Accretion of Series A redeemable convertible preferred stock to redemption value |
$ 8,578
|
|
|
|
|
|
| Ending temporary equity (in shares) at Jun. 30, 2025 |
150
|
|
|
|
|
|
| Ending temporary equity at Jun. 30, 2025 |
$ 150,241
|
|
|
|
|
|
| Beginning balance (in shares) at Dec. 31, 2024 |
|
|
258,173
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
(56,356)
|
52,375
|
$ 2
|
1,328,015
|
602
|
(1,384,975)
|
| Stockholders’ Equity |
|
|
|
|
|
|
| Unrealized (loss) gain on investments in marketable securities |
(38)
|
|
|
|
|
|
| Foreign currency translation gain (loss) |
(50)
|
|
|
|
|
|
| Accretion of redeemable noncontrolling interest to redemption value |
(1,254)
|
|
|
|
|
|
| Reclassification of noncontrolling interest to equity, net of noncash consideration received |
52,675
|
|
|
|
|
|
| Net loss |
(16,364)
|
|
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2025 |
|
|
260,051
|
|
|
|
| Ending balance at Jun. 30, 2025 |
(23,054)
|
0
|
$ 2
|
1,377,769
|
514
|
(1,401,339)
|
| Beginning temporary equity at Mar. 31, 2025 |
$ 145,865
|
|
|
|
|
|
| Beginning temporary equity (in shares) at Mar. 31, 2025 |
150
|
|
|
|
|
|
| Series A Redeemable Convertible Preferred Stock |
|
|
|
|
|
|
| Accretion of Series A redeemable convertible preferred stock to redemption value |
$ 4,376
|
|
|
|
|
|
| Ending temporary equity (in shares) at Jun. 30, 2025 |
150
|
|
|
|
|
|
| Ending temporary equity at Jun. 30, 2025 |
$ 150,241
|
|
|
|
|
|
| Beginning balance (in shares) at Mar. 31, 2025 |
|
|
258,825
|
|
|
|
| Beginning balance at Mar. 31, 2025 |
(17,173)
|
0
|
$ 2
|
1,376,752
|
565
|
(1,394,492)
|
| Stockholders’ Equity |
|
|
|
|
|
|
| Issuance of common stock upon exercise of stock options, net of repurchases (in shares) |
|
|
222
|
|
|
|
| Issuance of common stock upon exercise of stock options, net of repurchases |
430
|
|
|
430
|
|
|
| Vesting of restricted stock units (in shares) |
|
|
2,044
|
|
|
|
| Shares withheld related to net share settlement of equity awards (in shares) |
|
|
(695)
|
|
|
|
| Shares withheld related to net share settlement of equity awards |
(2,531)
|
|
|
(2,531)
|
|
|
| Stock-based compensation |
8,536
|
|
|
8,536
|
|
|
| Unrealized (loss) gain on investments in marketable securities |
(44)
|
|
|
|
(44)
|
|
| Foreign currency translation gain (loss) |
(7)
|
|
|
|
(7)
|
|
| Accretion of redeemable noncontrolling interest to redemption value |
0
|
|
|
|
|
|
| Accretion of Series A redeemable convertible preferred stock to redemption value |
(4,376)
|
|
|
(4,376)
|
|
|
| Share repurchases (in shares) |
|
|
(345)
|
|
|
|
| Share repurchases |
(1,042)
|
|
|
(1,042)
|
|
|
| Net loss |
(6,847)
|
|
|
|
|
(6,847)
|
| Ending balance (in shares) at Jun. 30, 2025 |
|
|
260,051
|
|
|
|
| Ending balance at Jun. 30, 2025 |
(23,054)
|
$ 0
|
$ 2
|
1,377,769
|
514
|
(1,401,339)
|
| Beginning temporary equity at Dec. 31, 2025 |
$ 159,495
|
|
|
|
|
|
| Beginning temporary equity (in shares) at Dec. 31, 2025 |
150
|
|
|
|
|
|
| Series A Redeemable Convertible Preferred Stock |
|
|
|
|
|
|
| Accretion of Series A redeemable convertible preferred stock to redemption value |
$ 4,731
|
|
|
|
|
|
| Ending temporary equity (in shares) at Mar. 31, 2026 |
150
|
|
|
|
|
|
| Ending temporary equity at Mar. 31, 2026 |
$ 164,226
|
|
|
|
|
|
| Beginning balance (in shares) at Dec. 31, 2025 |
256,043
|
|
256,043
|
|
|
|
| Beginning balance at Dec. 31, 2025 |
$ (30,473)
|
|
$ 2
|
1,360,704
|
597
|
(1,391,776)
|
| Stockholders’ Equity |
|
|
|
|
|
|
| Issuance of common stock upon exercise of stock options, net of repurchases (in shares) |
|
|
110
|
|
|
|
| Issuance of common stock upon exercise of stock options, net of repurchases |
96
|
|
|
96
|
|
|
| Vesting of restricted stock units (in shares) |
|
|
1,888
|
|
|
|
| Shares withheld related to net share settlement of equity awards (in shares) |
|
|
(664)
|
|
|
|
| Shares withheld related to net share settlement of equity awards |
(1,127)
|
|
|
(1,127)
|
|
|
| Stock-based compensation |
6,928
|
|
|
6,928
|
|
|
| Unrealized (loss) gain on investments in marketable securities |
(106)
|
|
|
|
(106)
|
|
| Foreign currency translation gain (loss) |
172
|
|
|
|
172
|
|
| Accretion of Series A redeemable convertible preferred stock to redemption value |
(4,731)
|
|
|
(4,731)
|
|
|
| Share repurchases (in shares) |
|
|
(10,041)
|
|
|
|
| Share repurchases |
(18,623)
|
|
|
(18,623)
|
|
|
| Net loss |
(8,049)
|
|
|
|
|
(8,049)
|
| Ending balance (in shares) at Mar. 31, 2026 |
|
|
247,336
|
|
|
|
| Ending balance at Mar. 31, 2026 |
(55,913)
|
|
$ 2
|
1,343,247
|
663
|
(1,399,825)
|
| Beginning temporary equity at Dec. 31, 2025 |
$ 159,495
|
|
|
|
|
|
| Beginning temporary equity (in shares) at Dec. 31, 2025 |
150
|
|
|
|
|
|
| Series A Redeemable Convertible Preferred Stock |
|
|
|
|
|
|
| Accretion of Series A redeemable convertible preferred stock to redemption value |
$ 9,658
|
|
|
|
|
|
| Ending temporary equity (in shares) at Jun. 30, 2026 |
150
|
|
|
|
|
|
| Ending temporary equity at Jun. 30, 2026 |
$ 169,153
|
|
|
|
|
|
| Beginning balance (in shares) at Dec. 31, 2025 |
256,043
|
|
256,043
|
|
|
|
| Beginning balance at Dec. 31, 2025 |
$ (30,473)
|
|
$ 2
|
1,360,704
|
597
|
(1,391,776)
|
| Stockholders’ Equity |
|
|
|
|
|
|
| Unrealized (loss) gain on investments in marketable securities |
(164)
|
|
|
|
|
|
| Foreign currency translation gain (loss) |
190
|
|
|
|
|
|
| Accretion of redeemable noncontrolling interest to redemption value |
0
|
|
|
|
|
|
| Reclassification of noncontrolling interest to equity, net of noncash consideration received |
0
|
|
|
|
|
|
| Net loss |
$ (9,532)
|
|
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2026 |
236,513
|
|
236,513
|
|
|
|
| Ending balance at Jun. 30, 2026 |
$ (74,374)
|
|
$ 2
|
1,326,309
|
623
|
(1,401,308)
|
| Beginning temporary equity at Mar. 31, 2026 |
$ 164,226
|
|
|
|
|
|
| Beginning temporary equity (in shares) at Mar. 31, 2026 |
150
|
|
|
|
|
|
| Series A Redeemable Convertible Preferred Stock |
|
|
|
|
|
|
| Accretion of Series A redeemable convertible preferred stock to redemption value |
$ 4,927
|
|
|
|
|
|
| Ending temporary equity (in shares) at Jun. 30, 2026 |
150
|
|
|
|
|
|
| Ending temporary equity at Jun. 30, 2026 |
$ 169,153
|
|
|
|
|
|
| Beginning balance (in shares) at Mar. 31, 2026 |
|
|
247,336
|
|
|
|
| Beginning balance at Mar. 31, 2026 |
(55,913)
|
|
$ 2
|
1,343,247
|
663
|
(1,399,825)
|
| Stockholders’ Equity |
|
|
|
|
|
|
| Vesting of restricted stock units (in shares) |
|
|
1,991
|
|
|
|
| Shares withheld related to net share settlement of equity awards (in shares) |
|
|
(636)
|
|
|
|
| Shares withheld related to net share settlement of equity awards |
(937)
|
|
|
(937)
|
|
|
| Stock-based compensation |
7,100
|
|
|
7,100
|
|
|
| Unrealized (loss) gain on investments in marketable securities |
(58)
|
|
|
|
(58)
|
|
| Foreign currency translation gain (loss) |
18
|
|
|
|
18
|
|
| Accretion of redeemable noncontrolling interest to redemption value |
0
|
|
|
|
|
|
| Accretion of Series A redeemable convertible preferred stock to redemption value |
(4,927)
|
|
|
(4,927)
|
|
|
| Share repurchases (in shares) |
|
|
(12,178)
|
|
|
|
| Share repurchases |
(18,174)
|
|
|
(18,174)
|
|
|
| Net loss |
$ (1,483)
|
|
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2026 |
236,513
|
|
236,513
|
|
|
|
| Ending balance at Jun. 30, 2026 |
$ (74,374)
|
|
$ 2
|
$ 1,326,309
|
$ 623
|
$ (1,401,308)
|